Fluid response and vein health during fluid bolus in ICU
Part of Heart & circulation clinical trials.
This trial looks at how well your body responds to extra fluids given through an IV, and whether it helps your veins. It is for people in the ICU who already have heart monitoring in place.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are currently in the intensive care unit (ICU).
- You have a monitor that tracks your heart's pumping strength (cardiac output) using a pulse wave.
- Your doctor has decided to give you extra fluids through an IV (a fluid bolus).
- You are not pregnant, and you or your family agree to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how tiny blood vessels respond to extra fluids in ICU patients who have vein congestion. It helps doctors understand if giving more fluid is helpful or harmful for you.
This trial studies how giving fluids affects blood buildup in the veins of critically ill heart patients in the ICU. It may help doctors decide how much fluid to give.
This study tests whether measuring the size of a vein in your groin using ultrasound can help doctors decide if you need more fluids when you're critically ill in the ICU. The goal is to improve how doctors manage fluid treatment for patients on breathing machines.
This study watches how the right side of your heart responds when doctors give you extra fluids to improve blood flow during a critical illness. Understanding this response may help doctors make better decisions about fluid treatment in the ICU.
This trial uses ultrasound to check for fluid buildup in veins of patients in the intensive care unit. It aims to see if this technique can help doctors manage treatment better.
This study looks at how a standard IV fluid bolus affects blood flow and heart function in ICU patients. It aims to better understand the body's response to this common treatment.
Hear when a new Fluid Responsiveness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.